Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?
Open Access
- 1 January 2009
- journal article
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 6 (1) , 4
Abstract
About 20–30% of persons with HIV infection, especially those living in countries with limited resources, experience an immune reconstitution inflammatory syndrome (IRIS) after starting antiretroviral treatment. The active form of vitamin D, 1,25-dihydroxyvitamin D, is a key player in the clearance of pathogens and influences the level of inflammation and macrophage activation.Keywords
This publication has 45 references indexed in Scilit:
- Vitamin D Status: Measurement, Interpretation, and Clinical ApplicationAnnals of Epidemiology, 2009
- Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settingsThe Lancet Infectious Diseases, 2008
- Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapyCurrent Opinion in HIV and AIDS, 2008
- Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective studyAIDS, 2008
- Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients Receiving Antiretroviral TherapyDrugs, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Life and death in the granuloma: immunopathology of tuberculosisImmunology & Cell Biology, 2007
- Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalaciaJournal of Clinical Investigation, 2006
- Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial ResponseScience, 2006
- Immune Reconstitution Inflammatory SyndromeMedicine, 2002